The University of Vermont Medical Center is a five-campus academic medical facility under the corporate umbrella of The University of Vermont Health Network corporate that is anchored by a 562-bed hospital. UVM is located in Burlington, Vermont, and serves as both a regional referral center and a community hospital.

There are 562 beds in Vermont Clinical Study Center.

During the past decade, Vermont Clinical Study Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vermont Clinical Study Center" #1 collaborator was "Dairy Research Institute" with 1 trials as a collaborator, "Janssen, LP" with 1 trials as a collaborator, "National Dairy Council" with 1 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator and "University of Vermont" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Vermont Clinical Study Center" are "ADHD" (4 trials), "Attention-Deficit/Hyperactivity Disorder" (2 trials), "ADHD Specifically With Executive Function Impairment" (1 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (1 trials) and "Dengue" (1 trials). Many other conditions were trialed in "Vermont Clinical Study Center" in a lesser frequency.

Most popular intervention types in "Vermont Clinical Study Center" are "Drug" (9 trials), "Dietary Supplement" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Control Fat" (1 trials), "Full-fat yogurt" (1 trials), "JNJ-64281802 (dosing regimen X)" (1 trials) and "JNJ-64281802 (dosing regimen Y)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vermont Clinical Study Center" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Vermont Clinical Study Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Vermont Clinical Study Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vermont Clinical Study Center, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".